|
|
||||||||
-Directed IgA Switching and Changes in B Cell Fate1







* Institute for Virology and Immunobiology,
Department of Physiological Chemistry II, Biocenter, and
Department of Physiological Chemistry I, Biocenter, University of Würzburg, Würzburg, Germany;
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029; and
¶ Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02115
Smad2 is a member of the intracellular mediators that transduce signals from TGF-
receptors and activin receptors. Targeted inactivation of Smad2 in mice leads to early lethality before gastrulation. It was shown previously that TGF-
RII deficiency in vivo leads to defects in B cell homeostasis, Ag responsiveness, and IgA class switch recombination of B cells. To investigate the importance of Smad2-mediated signaling in B lymphocytes, we generated a B cell-specific inactivation of Smad2 in mice (bSmad2/). bSmad2/ mice had normal B cell numbers in the spleen but showed a reduced population of marginal zone B cells. In contrast, B cells in Peyers patches and peritoneal B-1a cells of bSmad2/ mice were increased in numbers. bSmad2/ mice showed a reduced number of surface-IgA+ B cells and of IgA-secreting cells in Peyers patches, decreased levels of IgA in serum, and, after immunization with a T cell-dependent Ag, a reduced IgA response. Class switch recombination to IgA was impaired in Smad2-deficient B cells, when stimulated in vitro with LPS in the presence of TGF-
. The growth-inhibitory effects of TGF-
in LPS-stimulated B cells were not affected in Smad2-deficient B cells. In summary, our data indicate a crucial role of Smad2 in mediating signals for the TGF-
-directed class switch to IgA and the induction of IgA responses in vivo. Other B cell functions like growth-inhibitory signaling, which are known to be regulated by signals via the TGF-
R, are not affected in Smad2-deficient B cells.
Related articles in The JI:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |